FindTrial
Sign In

Retrospective study of cardiotoxicity in patients undergoing antitumor therapy

Retrospective study of cardiotoxicity in patients undergoing antitumor therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052626
Enrollment
Unknown
Registered
2021-11-02
Start date
2021-11-30
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac adverse reaction

Interventions

Case series:None

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years; 2. All patients receiving anti-tumor treatment in the research center; 3. Patients diagnosed as tumors by histopathology or cell pathology; 4. Voluntary participation in the trial.

Exclusion criteria

Exclusion criteria: 1. During pregnancy or lactation; 2. poor compliance; 3. The investigator did not consider it appropriate to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Tumor markers;electrocardiogram;Echocardiography;Cardiac magnetic resonance;—

Countries

China

Contacts

Public ContactChen Leilei

Zhongshan Hospital, Fudan University

cheng.leilei@zs-hospital.sh.cn+86 13916866296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026